Estimated Cost of Circulating Tumor DNA for Posttreatment Surveillance of Human Papillomavirus–Associated Oropharyngeal Cancer

This cross-sectional study compares the cost and effectiveness of 3 posttreatment strategies for surveillance of human papillomavirus (HPV)–associated oropharyngeal cancer.

Detalles Bibliográficos
Autores principales: Kowalchuk, Roman O., Kamdem Talom, Benjamin C., Van Abel, Kathryn M., Ma, Daniel M., Waddle, Mark R., Routman, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790672/
https://www.ncbi.nlm.nih.gov/pubmed/35076706
http://dx.doi.org/10.1001/jamanetworkopen.2021.44783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790672/
https://www.ncbi.nlm.nih.gov/pubmed/35076706
http://dx.doi.org/10.1001/jamanetworkopen.2021.44783

Ejemplares similares